Patents/Assignees

NANJING IMMUNOPHAGE BIOTECH CO., Ltd.

3 patents in portfolio

US12497453utility2025
ROR1 Specific Chimeric Antigen Receptors and Their Therapeutic Applications
0 cites
US12441795utility2025
Anti-ror1 Antibodies and Preparation Method and Uses Thereof
0 cites
US11884682utility2024
Compounds and Their Uses as MIF Inhibitors
0 cites